{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:35:54Z","timestamp":1761395754609,"version":"3.44.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jpeds.2020.05.041","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T11:20:30Z","timestamp":1590492030000},"page":"80-89.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-4788","authenticated-orcid":false,"given":"Rebecca","family":"MacDonell-Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"DeNardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa","family":"Sprinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William V.","family":"Padula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2020.05.041_bib1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1634\/theoncologist.2008-0011","article-title":"Liver tumors in children","volume":"13","author":"Litten","year":"2008","journal-title":"Oncologist"},{"year":"2015","series-title":"Nathan and Oski's hematology and oncology of infancy and childhood","author":"Orkin","key":"10.1016\/j.jpeds.2020.05.041_bib2"},{"key":"10.1016\/j.jpeds.2020.05.041_bib3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamasurg.2015.1847","article-title":"Effect\u00a0of liver transplant on long-term disease-free survival in children with hepatoblastoma and hepatocellular cancer","volume":"150","author":"Pham","year":"2015","journal-title":"JAMA Surg"},{"year":"2011","series-title":"SEER cancer statistics review, 1975-2008","key":"10.1016\/j.jpeds.2020.05.041_bib4"},{"key":"10.1016\/j.jpeds.2020.05.041_bib5","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","article-title":"Pretreatment prognostic factors for children with hepatoblastoma- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1","volume":"36","author":"Brown","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib6","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1200\/JCO.2010.29.3837","article-title":"Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group","volume":"29","author":"Malogolowkin","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib7","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1200\/JCO.2002.07.400","article-title":"Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study","volume":"20","author":"Katzenstein","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0022-3468(75)90095-0","article-title":"Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics surgical section survey\u20141974","volume":"10","author":"Exelby","year":"1975","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpeds.2020.05.041_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/bjs.1800820334","article-title":"Improved outcome for children with hepatoblastoma","volume":"82","author":"Stringer","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.jpeds.2020.05.041_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1023\/A:1018815802500","article-title":"Ultrasound-guided liver biopsy for parenchymal liver disease: an economic analysis","volume":"43","author":"Younossi","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jpeds.2020.05.041_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1067\/mic.2001.111536","article-title":"Changing concepts in long-term central venous access: catheter selection and cost savings","volume":"29","author":"Horattas","year":"2001","journal-title":"Am J Infection Control"},{"key":"10.1016\/j.jpeds.2020.05.041_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.surg.2015.03.033","article-title":"Net health benefit of hepatic resection versus intraarterial therapies for neuroendocrine liver metastases: a Markov decision model","volume":"158","author":"Spolverato","year":"2015","journal-title":"Surgery"},{"year":"2006","series-title":"Pediatric cancer hospitalizations, 2009: statistical brief #132. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Price","key":"10.1016\/j.jpeds.2020.05.041_bib14"},{"key":"10.1016\/j.jpeds.2020.05.041_bib15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/petr.12783","article-title":"Variation in resource utilization in liver transplantation at freestanding children's hospitals","volume":"20","author":"Minneman","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpeds.2020.05.041_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jamcollsurg.2007.06.292","article-title":"Incremental costs of post-liver transplantation complications","volume":"206","author":"Ammori","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jpeds.2020.05.041_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-3046.2006.00639.x","article-title":"Health insurance considerations for adolescent transplant recipients as they transition to adulthood","volume":"11","author":"Willoughby","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpeds.2020.05.041_bib18","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.283.18.2445","article-title":"Payment for immunosuppression after organ transplantation. American Society of Transplantation","volume":"283","author":"Kasiske","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2020.05.041_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.surg.2012.11.006","article-title":"Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities","volume":"153","author":"Cruz","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.jpeds.2020.05.041_bib20","doi-asserted-by":"crossref","first-page":"e5858","DOI":"10.1097\/MD.0000000000005858","article-title":"Hepatoblastoma in an 11-year-old: case report and a review of the literature","volume":"96","author":"Pateva","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.jpeds.2020.05.041_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1096-911X(199803)30:3<141::AID-MPO1>3.0.CO;2-H","article-title":"Hepatoblastoma incidence in the United States from 1973 to 1992","volume":"30","author":"Ross","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2217\/hep.13.2","article-title":"What do we know about the etiology of hepatoblastoma?","volume":"1","author":"Turcotte","year":"2014","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1542\/peds.2008-3069","article-title":"Cancer risk among children with very low birth weights","volume":"124","author":"Spector","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.05.041_bib25","doi-asserted-by":"crossref","first-page":"E555","DOI":"10.1002\/ijc.27351","article-title":"Hepatoblastoma in the Nordic countries","volume":"131","author":"de Fine Licht","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/jpsu.2003.50027","article-title":"Hepatoblastoma in children of extremely low birth weight: a report from a single perinatal center","volume":"38","author":"Oue","year":"2003","journal-title":"J Pediatr Surg"},{"year":"2017","series-title":"Births: final data for 2015. National vital statistics reports","author":"Martin","key":"10.1016\/j.jpeds.2020.05.041_bib27"},{"key":"10.1016\/j.jpeds.2020.05.041_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1067\/S0022-3476(03)00306-8","article-title":"Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia","volume":"143","author":"Clericuzio","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2020.05.041_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/ped.13090","article-title":"Serum alpha-fetoprotein concentration in extremely low-birthweight infants","volume":"59","author":"Maruyama","year":"2017","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2020.05.041_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mpo.1209","article-title":"Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model","volume":"37","author":"McNeil","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/(SICI)1096-911X(199906)32:6<466::AID-MPO20>3.0.CO;2-1","article-title":"Congenital hepatoblastoma: a distinct entity?","volume":"32","author":"Ammann","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12253-008-9001-8","article-title":"A prenatally detected case of congenital hepatoblastoma","volume":"14","author":"Ergin","year":"2008","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jpeds.2020.05.041_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26791","article-title":"Hepatoblastoma in children aged less than six months at diagnosis: a report from the SIOPEL group","volume":"65","author":"Dall'Igna","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1651-2227.2008.01087.x","article-title":"Exposure of extremely low birth weight infants to diagnostic X-Rays: a longitudinal study","volume":"98","author":"Arad","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpeds.2020.05.041_bib35","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ejca.2011.12.011","article-title":"Prognostic stratification for children with hepatoblastoma: the SIOPEL experience","volume":"48","author":"Maibach","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21037\/tgh.2016.04.01","article-title":"Pediatric liver transplantation for hepatoblastoma","volume":"1","author":"Trobaugh-Lotrario","year":"2016","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib37","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/pbc.22088","article-title":"Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group","volume":"53","author":"Meyers","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children's Hepatic tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/jgh.13165","article-title":"Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: a Chinese population-based study","volume":"31","author":"Qiao","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOP.0000000000000042","article-title":"Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation","volume":"26","author":"Meyers","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jpeds.2020.05.041_bib41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1634\/theoncologist.5-6-445","article-title":"Childhood cancers: hepatoblastoma","volume":"5","author":"Herzog","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.jpeds.2020.05.041_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0022-3468(75)90095-0","article-title":"Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey--1974","volume":"10","author":"Exelby","year":"1975","journal-title":"J Pediatr Surg"},{"year":"2016","series-title":"Cost-effectiveness in health and medicine","author":"Neumann","key":"10.1016\/j.jpeds.2020.05.041_bib43"},{"key":"10.1016\/j.jpeds.2020.05.041_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejca.2016.05.013","article-title":"European cost-effectiveness study of uPA\/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer","volume":"63","author":"Marguet","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00005650-200006000-00004","article-title":"One thousand health-related quality-of-life estimates","volume":"38","author":"Tengs","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.jpeds.2020.05.041_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/phar.1870","article-title":"Cost-effectiveness analysis of second-line chemotherapy agents for advanced gastric cancer","volume":"37","author":"Lam","year":"2017","journal-title":"Pharmacotherapy"},{"year":"2010","series-title":"Economic evaluation in child health","author":"Ungar","key":"10.1016\/j.jpeds.2020.05.041_bib47"},{"key":"10.1016\/j.jpeds.2020.05.041_bib49","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1600-6143.2012.04080.x","article-title":"Health status in young adults two decades after pediatric liver transplantation","volume":"12","author":"Mohammad","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jpeds.2020.05.041_bib50","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.163.14.1637","article-title":"What is the price of life and why doesn't it increase at the rate of inflation?","volume":"163","author":"Ubel","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpeds.2020.05.041_bib51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MLR.0b013e31815c31a7","article-title":"What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?","volume":"46","author":"Braithwaite","year":"2008","journal-title":"Med Care"},{"key":"10.1016\/j.jpeds.2020.05.041_bib52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2020.05.041_bib53","first-page":"14","article-title":"CVS and the $100,000 QALY","volume":"27","author":"Silverman","year":"2018","journal-title":"Manage Care"},{"key":"10.1016\/j.jpeds.2020.05.041_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamapediatrics.2018.0049","article-title":"Considerations for cost-effectiveness analysis of curative pediatric therapies","volume":"172","author":"Whittington","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2020.05.041_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-2277.2011.01327.x","article-title":"Rationing life-saving resources--how should allocation policies be assessed in solid organ transplantation","volume":"25","author":"Neuberger","year":"2012","journal-title":"Transplant Int"},{"key":"10.1016\/j.jpeds.2020.05.041_bib56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2165\/11590130-000000000-00000","article-title":"Pharmacoeconomics of the myeloid growth factors: a critical and systematic review","volume":"30","author":"Hirsch","year":"2012","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.jpeds.2020.05.041_bib57","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2165\/11592980-000000000-00000","article-title":"Costs associated with febrile neutropenia in the US","volume":"30","author":"Michels","year":"2012","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.jpeds.2020.05.041_bib58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/PCC.0000000000001154","article-title":"Relationship of hospital costs with mortality in pediatric critical care: a multi-institutional analysis","volume":"18","author":"Gupta","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jpeds.2020.05.041_bib59","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2956","article-title":"Children's end-of-life health care use and cost","volume":"139","author":"Widger","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.05.041_bib60","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1542\/peds.2011-3028","article-title":"Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009","volume":"129","author":"Horbar","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.05.041_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force\u00a0on Good Research Practices--Modeling Studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"year":"2017","series-title":"Bright Futures: guidelines for health supervision of infants, children, and adolescents","key":"10.1016\/j.jpeds.2020.05.041_bib62"},{"key":"10.1016\/j.jpeds.2020.05.041_bib63","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.3928\/19382359-20180325-03","article-title":"Follow-up care for high-risk preterm infants","volume":"47","author":"Voller","year":"2018","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.jpeds.2020.05.041_bib64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.pcl.2018.12.014","article-title":"Care of the neonatal intensive care unit graduate after discharge","volume":"66","author":"Goldstein","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jpeds.2020.05.041_bib65","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/pch\/pxx058","article-title":"Counselling and management for anticipated extremely preterm birth","volume":"22","author":"Lemyre","year":"2017","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.jpeds.2020.05.041_bib66","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.semperi.2013.06.028","article-title":"Periviable births: communication and counseling before delivery","volume":"37","author":"Srinivas","year":"2013","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib67","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1002\/cncr.30904","article-title":"Psychological distress associated with cancer screening: a systematic review","volume":"123","author":"Chad-Friedman","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2188\/jea.JE20160038","article-title":"Neuroblastoma mass screening--what can we learn from it?","volume":"26","author":"Katanoda","year":"2016","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jpeds.2020.05.041_bib69","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1200\/JCO.1998.16.4.1265","article-title":"Spontaneous regression of localized neuroblastoma detected by mass screening","volume":"16","author":"Yamamoto","year":"1998","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2020.05.041_bib70","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0378-3782(13)70020-3","article-title":"Survival rate and prevalence of bronchopulmonary dysplasia in extremely low birth weight infants","volume":"89","author":"Latini","year":"2013","journal-title":"Early Human Dev"},{"key":"10.1016\/j.jpeds.2020.05.041_bib71","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2020.05.041_bib72","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cncr.23169","article-title":"Trends in childhood cancer incidence in the U.S. (1992-2004).","volume":"112","author":"Linabery","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jpeds.2020.05.041_bib73","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0277-9536(03)00254-5","article-title":"Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons.","volume":"58","author":"Feeny","year":"2004","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jpeds.2020.05.041_bib74","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0272989X06290495","article-title":"Preference-based EQ-5D index scores for chronic conditions in the United States.","volume":"26","author":"Sullivan","year":"2006","journal-title":"Medical Decision Making"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234762030679X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234762030679X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:06:43Z","timestamp":1758359203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002234762030679X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":73,"alternative-id":["S002234762030679X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2020.05.041","relation":{},"ISSN":["0022-3476"],"issn-type":[{"type":"print","value":"0022-3476"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2020.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}